Motor evoked potentials and disability in secondary progressive multiple sclerosis

Canadian Journal of Neurological Sciences

Volumn 24, Issue 4, 1997, Pages 332-337

  Facchetti, D ^a,d   Mai, R ^a   Micheli, A ^a   Marciano N ^b   Capra, R ^b   Gasparotti, R ^b   Poloni, M ^c  

^a IRCCS   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d Centro Medico di Gussago   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; EVOKED MUSCLE RESPONSE; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NERVE CONDUCTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL DISABILITY; PRIORITY JOURNAL; PYRAMIDAL TRACT; SPINAL CORD STIMULATION;

EID: 0031406381     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0317167100033011     Document Type: Article

References (50)

1. Barker AT, Jalinous R, Freeston IL. Non-invasive magnetic stimulation of human motor cortex. Lancet 1985; i: 1106-1107.
2. Hess CW, Mills KR, Murray NMF. Measurement of central motor conduction in multiple sclerosis by magnetic brain stimulation. Lancet 1986; 16: 355-358.
3. Booth KR, Streletz LJ, Raab VE, et al. Motor evoked potentials and central motor conduction: studies of transcranial magnetic stimulation with recording from the leg. Electroencephalogr Clin Neurophysiol 1990; 81: 57-62.
4. Murray NMF. The clinical usefulness of magnetic cortical stimulation. Electroencephalogr Clin Neurophysiol 1992; 85: 81-85.
5. Kidd D, Thompson AJ, Kendall BE, Miller DH, McDonald WI. Benign form of multiple sclerosis: MRI evidence for less frequent and less inflammatory disease activity. J Neurol Neurosurg Psychiatry 1994; 57: 1070-1072.
6. Wiebe S, Lee DH, Karlik SJ, et al. Serial cranial and spinal cord magnetic resonance imaging in multiple sclerosis. Ann Neurol 1992; 32: 643-646.
7. Thompson AJ, Miller D, Youl B, et al. Serial gadolinium-enhanced MRI in relapsing-remitting multiple sclerosis of varying disease duration. Neurology 1992; 42: 60-63.
8. Tartaglino LM, Friedman DP, Flanders AE, et al. Multiple sclerosis in the spinal cord: MR appearance and correlation with clinical parameter. Radiology 1995; 195: 725-732.
9. Kidd D, Thorpe JW, Thompson AJ, et al. Spinal cord MRI using multi-array coils and fast spin echo. II. Findings in multiple sclerosis. Neurology 1993; 43: 2632-2637.
10. Koopmans RA, Li DKB, Grochowski E, Curler PJ, Pary DW. Benign versus chronic progressive multiple sclerosis: magnetic resonance imaging features. Ann Neurol 1989; 25: 74-81.
11. Poser CM, Paty DW, Sheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983,12: 227-231.
12. Eisen AA, Shtybel W. AAEM minimonograph #35; clinical experience with transcranial magnetic stimulation. Muscle and Nerve 1990; 13: 995-1011.
13. Eisen AA. Noninvasive measurement of spinal cord conduction: review of presently available methods. Muscle and Nerve 1986; 9: 95-103.
14. Snooks SJ, Swash M. Motor conduction velocity in the human spinal cord: slowed conduction in multiple sclerosis and radiation myelopathy. J Neurol Neurosurg Psychiatry 1985; 48: 1135-1139.
15. Fujiki M, Isono M, Hori S, Ueno S. Corticospinal direct response to transcranial magnetic stimulation in humans. Electroencephologr Clin Neurophysiol 1996; 10: 48-57.
16. Kutzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale. Neurology 1983; 33: 1444-1452.
17. Ravnborg M, Liguori R, Christiansen P, Larsson H, Soelberg-Sørensen P. The diagnostic reliability of magnetically evoked motor potentials in multiple sclerosis. Neurology 1992; 42: 1296-1301.
18. Berardelli A, Inghilleri M, Cruccu G, et al. Stimulation of motor tracts in multiple sclerosis. J Neurol Neurosurg Psychiatry 1988; 51: 677-683.
19. Caramia MD, Bernardi G, Zarola F, Rossini PM. Neurophysiological evaluation of the central nervous impulse propagation in patients with scnsorimotor disturbances. Electroencephalogr Clin Neurophysiol 1988; 70: 16-25.
20. Filippi M, Campi A, Mammi S, et al. Brain magnetic resonance imaging and multimodal evoked potentials in benign and secondary progressive multiple sclerosis. J Neurol Neurosurg Psychiatry 1995; 58: 31-37.
21. Hess CW, Mills KR, Murray NMF, Schriefer TN. Magnetic brain stimulation: central motor conduction studies in multiple sclerosis. Ann Neurol 1987; 22: 744-752.
22. Jones SM, Streletz LJ, Raab VE, Knobler RL, Lublin FD. Lower extremity motor evoked potentials in multiple sclerosis. Arch Neurol 1991; 48: 944-948.
23. Chiappa KH. Evoked Potentials in Clinical Medicine. Second edition. 1990. Raven Press. New York.
24. Khoshbin S, Hallett M. Multimodality evoked potentials and blink reflex in multiple sclerosis. Neurology 1981; 31: 138-144.
25. Mills KR, Murray NMF. Corticospinal tract conduction time in multiple sclerosis. Ann Neurol 1985; 18: 601-605.
26. Smith SJM, Claus D, Hess CW, et al. F responses and central motor conduction in multiple sclerosis. Electroencephalogr Clin Neurophysiol 1989; 74: 438-443.
27. Kandler RH, Jarrat JA, Davies-Jones GAB, et al. The role of magnetic stimulation as a quantifier of motor disability in patients with multiple sclerosis. J Neurol Sci 1991; 106: 31-34.
28. Berger AR, Shahani BT. Electrophysiologic evaluation of spinal cord motor conduction. Muscle Nerve 1989; 12: 976-980.
29. Beer S, Rosler KM, Hess CW. Diagnostic value of paraclinical tests in multiple sclerosis: relative sensitivities and specificities for reclassification according to the Poser committee criteria. J Neurol Neurosurg Psychiatry 1995; 59: 152-159.
30. Mayr N, Baumgartner C, Zeitlhofer J, Deecke L. The sensitivity of transcranial cortical magnetic stimulation in detecting pyramidal tract lesions in clinically definite multiple sclerosis. Neurology 1991; 41: 566-569.
31. Ingram DA, Thompson AJ, Swash M. Central motor conduction in multiple sclerosis: evaluation of abnormalities revealed by transcutaneous magnetic stimulation of the brain. J Neurol Neurosurg Psychiatry 1988; 51: 487-494.
32. Kandler RH, Jarrat JA, Gumpert EJW, et al. The role of magnetic stimulation in the diagnosis of multiple sclerosis. J Neurol Sci 1991; 106: 25-30.
33. Smith ME, Stone LA, Albert PS, et al. Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumin-enhancing magnetic resonance imaging lesions. Ann Neurol 1993; 33: 480-489.
34. Miller DH, Barkhof F, Nauta JP. Gadolinium enhancement increases the sensitivity of MRI in detecting disease activity in multiple sclerosis. Brain 1993; 116: 1077-1079.
35. Baumhefner RW, Tourtellotte WW, Syndulko K, et al. Quantitative multiple sclerosis plaque assessment with magnetic resonance imaging. Its correlation with clinical parameters, evoked potentials and intra-blood-brain barrier IgG synthesis. Arch Neurol 1990; 47: 19-26.
36. Cutler JR, Aminoff MJ, Brant-Zavadazki M. Evaluation of patients with multiple sclerosis by evoked potentials and magnetic resonance imaging: a comparative study. Ann Neurol 1986; 20: 645-648.
37. Miller DH. Magnetic resonance in monitoring the treatment of multiple sclerosis. Ann Neurol 1994; 36: S91-S94.
38. Paty DW, Li DK, Oger JF, et al. Magnetic resonance imaging in the evaluation of clinical trials in multiple sclerosis. Ann Neurol 1994; 36: S95-S96.
39. Capra R, Marciano' N, Vignolo L, Chiesa A, Gasparotti R. Gadolinium-pentetic acid magnetic resonance imaging in patients with relapsing-remitting multiple sclerosis. Arch Neurol 1992; 49: 687-689.
40. Stone LA, Albert PS, Smith ME, et al. Changes in the amount of diseased white matter over time in patients with relapsing remitting multiple sclerosis. Neurology 1995; 45: 1808-1814.
41. The IFNβ multiple sclerosis study group. Interferon β-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicentre, randomized, double blind placebo controlled trial. Neurology 1993; 43: 655-661.
42. Paty DW, Oger JF, Kastruokoff LF, et al. MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding and CT. Neurology 1988; 38: 180-185.
43. McDonald WI, Miller DH, Thompson AJ. Are magnetic resonance findings predictive of clinical outcome in therapeutic trials in multiple sclerosis? The dilemma of interferon-β. Ann Neurol 1994; 36: 14-18.
44. Khoury SJ, Guttman CRG, Oraw EJ, et al. Longitudinal MRI in multiple sclerosis: correlation between disability and lesion burden. Neurology 1994; 44: 2120-2124.
45. Paty DW. Li DKB, the UBC MS/MRI study group and the INFβ multiple sclerosis study group. Interferon β-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicentre, randomized, double blind, placebo controlled, trial. Neurology 1993; 43: 662-667.
46. Grossman RI. Magnetization transfer in multiple sclerosis. Ann Neurol 1994; 36: S97-S99.
47. Filippi M, Capra R, Campi A, et al. Triple dose of gadolinium-DTPA and delayed MRI in patients with benign multiple sclerosis. J Neurol Neurosurg Psychiatry 1996; 60: 526-530.
48. Evans AC, Frank JA, Antel J, Miller DH. The role of MRI in clinical trials: comparison of image processing tecnique. Ann Neurol 1997; 41: 125-132.
49. IFNβ Multiple Sclerosis Study Group and the University of British Columbia MS/MRI Analysis Group. Interferon β-1b in the treatment of multiple sclerosis: final outcome of the randomized contolled trial. Neurology 1995; 45: 1277-1285.
50. Kidd D, Thorphe JW, Kendal BE, et al. MRI dynamics of spinal cord in progressive multiple sclerosis. J Neurol Neurosurg Psychiatry 1996; 60: 15-19.